Carl Zeiss Meditec AG Capital Reinvestment Ratio
Carl Zeiss Meditec AG capital reinvestment ratio. Carl Zeiss Meditec AG (AFX) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (€209.86 Million) in capital expenditures (€76.59 Million). See Carl Zeiss Meditec AG free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Carl Zeiss Meditec AG (2014–2025)
Capital reinvestment ratio of Carl Zeiss Meditec AG from 2014 to 2025. This chart tracks Carl Zeiss Meditec AG's Capital Reinvestment Ratio across 12 annual periods. See Carl Zeiss Meditec AG (AFX) flexibility index to measure the company's free cash flow as a share of total liabilities.
Carl Zeiss Meditec AG Capital Reinvestment Ratio by Year (2014–2025)
Carl Zeiss Meditec AG capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Carl Zeiss Meditec AG.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | €209.86 Million | €76.59 Million | ▼ -40.7% |
| 2024 | 0.62x | €247.32 Million | €152.20 Million | ▲ +135.2% |
| 2023 | 0.26x | €250.86 Million | €65.65 Million | ▲ +15.1% |
| 2022 | 0.23x | €188.20 Million | €42.80 Million | ▲ +173.8% |
| 2021 | 0.08x | €362.66 Million | €30.12 Million | ▼ -49.4% |
| 2020 | 0.16x | €178.53 Million | €29.32 Million | ▲ +77.3% |
| 2019 | 0.09x | €219.63 Million | €20.35 Million | ▲ +4.9% |
| 2018 | 0.09x | €187.21 Million | €16.54 Million | ▼ -75.6% |
| 2017 | 0.36x | €37.73 Million | €13.66 Million | ▲ +44.9% |
| 2016 | 0.25x | €111.77 Million | €27.92 Million | ▲ +45.0% |
| 2015 | 0.17x | €56.74 Million | €9.77 Million | ▼ -2.5% |
| 2014 | 0.18x | €63.10 Million | €11.14 Million | — |